Logo 6 a1e69dad97a22b9caa5aa6c606f6ea7f9e9b8c4d0352141ae8a7e9bed5512ee3
  • Antibodies
  • Assays/Kits
  • Proteins/Peptides
  • siRNAs/Functional Genomics
  • Biochemicals
  • cDNA Clones
  • Cell/Tissue/Blood Products
  • Genes
  • Images

CCG 203971

Name CCG 203971
Supplier R&D Systems
Catalog 5277
Prices $99.00, $419.00
Sizes 10 mg, 50 mg
Cas Number 1443437-74-8
Chemical Name N-(4-Chlorophenyl)-1-[3-(2-furanyl)benzoyl]-3-piperidinecarboxamide
Formula C23H21ClN2O3
Molecular Weight 408.88
Purity >98%
Supplier Page Shop

Product References

Hope for disease-modifying treatment of systemic sclerosis/scleroderma. - Hope for disease-modifying treatment of systemic sclerosis/scleroderma.

Michel MC. J Pharmacol Exp Ther. 2014 Sep;350(3):480-2.

Optimization of novel nipecotic bis(amide) inhibitors of the Rho/MKL1/SRF - Optimization of novel nipecotic bis(amide) inhibitors of the Rho/MKL1/SRF

Bell JL, Haak AJ, Wade SM, Kirchhoff PD, Neubig RR, Larsen SD. Bioorg Med Chem Lett. 2013 Jul 1;23(13):3826-32.

Targeting the myofibroblast genetic switch: inhibitors of myocardin-related - Targeting the myofibroblast genetic switch: inhibitors of myocardin-related

Haak AJ, Tsou PS, Amin MA, Ruth JH, Campbell P, Fox DA, Khanna D, Larsen SD, Neubig RR. J Pharmacol Exp Ther. 2014 Jun;349(3):480-6.



Privacy
Terms
About us
Contact us

Copyright© 2025. All Rights Reserved